China Resources Pharmaceutical (03320.HK) has released its interim results, with a net profit attributable to shareholders of 2.077 billion yuan, a decrease of 20.25% compared to the same period last year. The interim dividend per share is 0.072 yuan.

Zh tng cijng APP xn, hurn yyo (03320.HK) fb 2025 nin zhngq yj, gi jtun qd shuy rnmnb 1318.67 y yun (dnwi xi tng), tngb zngji 2.54%; gngs quny gdng yng zhn yl 20.77 y yun, tngb jinsho 20.25%; mig yngl 0.33 yun, n pif zhngq gx mig 0.072 yun. Wisdom Finance APP News, China Resources Pharmaceutical (03320.HK) released its mid-term performance for 2025, with the group achieving revenue of 1318.67 billion yuan (unit same), a year-on-year increase of 2.54%; the net profit attributable to equity shareholders of the company was 20.77 billion yuan, a year-on-year decrease of 20.25%; earnings per share were 0.33 yuan, with a proposed mid-term dividend of 0.072 yuan per share.